The #startup OncoDiag, accompanied by Agoranov in 2014, raises a €2.5m #SérieA de 2,5 M€ to develop its early cancer diagnosis tests. 🎉
🤝 The raising is done with several groups of business angels, including historical investors: Angels Santé, BADGE Business Angels des Grandes Ecoles, Normandie Business Angels, new entrants: Paris Business Angels and SOCIETE DE FINANCEMENT DE L'INNOVATION NUMERIQUE EN ESSONNE and grants from Bpifrance and Normandie Participations.
💬 «For the whole team, it is a great pride to work on improving #cancer screening and diagnosis in the simplest and least invasive way possible» - Claude Hennion, CEO of OncoDiag.
👏 Congrats to the team!
👉 For more information: https://bit.ly/3tmkkxG.